- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01689480
Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program. (FSHD2)
Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With Facioscapulohumeral Dystrophy : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present project is the second phase of a study for which the first phase currently financed by AFM is in progress and aims to establish a program of adapted physical training performed at the patient's home under supervision. This program was developed in order to try to meet the two following requirements: 1) to be compatible with the daily professional/social activity of patients so it can be integrated in their life routine; 2) to be intense enough so functional benefits can be induced. The first phase is a controlled and randomized study where patients with FSHD participate in a 6-months supervised training program combining aerobic and strength training sessions on an ergocycle.
This second phase of our research project aims to evaluate whether a long-term integration of this adapted training program into patients' lifestyle is possible. The same tools, same method and same measurements of training program will be used with remote monitoring, less frequent as it was in the first phase, over a period of 24 months. This second experimental work will also be based on multi-factorial evaluations, i.e. biological, physiological, functional, and quality of life questionnaires and remains collaboration between Universities of Saint Etienne (L. Féasson), Grenoble (B Wuyam) and Örebro (F Kadi) within the Rhône-Alpes Reference Centre for Rare Neuromuscular Diseases (JC Antoine).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38000
- CHU de Grenbole
-
Saint-etienne, France, 42000
- CHU de Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Included in the FSHD1 study
- Social Security regimen affiliated
- Consent form signed
Exclusion Criteria:
- Severe cardiac or respiratory insufficiency
- Cardiac pacemaker
- Morbid obesity (BMI upper to 35)
- Anti platelet therapy
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
FSHD training
Only the patients who have participated to the FSHD1 study (NCT01116570) can be included in this study.
|
The training will consist in 3 sessions of 35 min of training per week at home on an ergocycle.
The training will be divided in (i) 2 sessions of 30 min aerobic exercises at a constant but moderate (60% of maximal aerobic power, MAP) intensity followed with 5 sets of 10 revolutions at near-maximal intensity and (ii) an interval-training session.
This latter session will consist in 5 min warm-up at 40% MAP followed by 5 times 1 min at 80% MAP (recovery = 4 min at 40% MAP) followed by 5 min of active recovery.
A systematic supervision of the sessions by the coach will be performed by phone, by using the heart rate recordings and values of Analogic Visual Scale for pain and fatigue.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patient's compliance
Time Frame: at 24 months
|
Number of adapted physical activity sessions conducted over 2 years in patients with FSHD based on a theoretical program of three weekly sessions.
A session will be considered valid based on the collection 1) time physical activity actually performed and 2) its intensity, both recorded from the cycle ergometer and a heart rate record.
|
at 24 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Léonard FEASSON, MD PhD, CHU de Saint-Etienne
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1108153
- 2011-A01186-35 (Other Identifier: AFSSAPS)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Dystrophy, Facioscapulohumeral
-
FSHD SocietyRecruitingFacioscapulohumeral Muscular Dystrophy | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facioscapulohumeral Muscular Dystrophy (FSHD) | FSHD - Facioscapulohumeral Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | Facioscapulohumeral Muscular Dystrophy 2 | FSH Muscular Dystrophy and other conditionsUnited States
-
Avidity Biosciences, Inc.Active, not recruitingMuscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, Canada, United Kingdom
-
Avidity Biosciences, Inc.CompletedMuscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, Canada, United Kingdom
-
Avidity Biosciences, Inc.RecruitingFacioscapulohumeral Muscular Dystrophy | FSHD | Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) | Facio-Scapulo-Humeral Dystrophy | FSHD - Facioscapulohumeral Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral... and other conditionsUnited States, Denmark, Spain, Canada, United Kingdom, Italy, Germany, France, Japan, Netherlands
-
Koç UniversityCompletedFacioscapulohumeral Muscular Dystrophy | Neuromuscular Disease | Facioscapulohumeral Muscular Dystrophy 1Turkey (Türkiye)
-
Centre Hospitalier Universitaire DijonRecruitingFacioscapulohumeral DystrophyFrance
-
Radboud University Medical CenterRecruitingFSHD - Facioscapulohumeral Muscular DystrophyNetherlands
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, France, Italy
-
Centre Hospitalier Universitaire de NiceCompletedType 1 Facioscapulohumeral Muscular DystrophyFrance
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, Netherlands, France, Italy
Clinical Trials on FSHD training
-
University of Kansas Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); University... and other collaboratorsActive, not recruitingFacioscapulohumeral Muscular DystrophyUnited States, France, Germany, Italy, Netherlands, United Kingdom
-
Centre Hospitalier Universitaire de NiceActive, not recruitingMuscular Dystrophy | FacioscapulohumeralFrance
-
Centre Hospitalier Universitaire de NiceActive, not recruitingFacioscapulohumeral Muscular DystrophyFrance
-
Northeastern UniversityOregon Health and Science University; University of California, RiversideRecruiting
-
University Hospital, MontpellierHospital Clinical Research Project 2010; Association Amis FSH France; FSH Dutch...CompletedFacioscapulohumeral Muscular DystrophyFrance
-
University of Trás-os-Montes and Alto DouroCompletedLipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary HypertensionPortugal
-
New Jersey Institute of TechnologyRutgers, The State University of New JerseyCompletedHemiplegia | Hemiparesis | Cerebrovascular AccidentUnited States
-
Foundation for Atlanta Veterans Education and Research...United States Department of Defense; NYU Langone Health; University of Rochester and other collaboratorsRecruitingStress Disorders, Post-TraumaticUnited States
-
Lebanese UniversityCompletedHeart Failure | Quality of Life | Cardiac Rehabilitation | Aerobic Exercise | Exercise Intolerance | Respiratory Muscle Training | Strength Training